Risk factors for primary congenital glaucoma in the National Birth Defects Prevention Study

被引:15
作者
Forestieri, Nina E. [1 ]
Desrosiers, Tania A. [2 ]
Freedman, Sharon F. [3 ]
Aylsworth, Arthur S. [4 ]
Voltzke, Kristin [2 ]
Olshan, Andrew F. [2 ]
Meyer, Robert E. [1 ,5 ]
机构
[1] State Ctr Hlth Stat, North Carolina Birth Defects Monitoring Program, Raleigh, NC USA
[2] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA
[3] Duke Univ, Med Ctr, Dept Ophthalmol & Pediat, Durham, NC USA
[4] Univ N Carolina, Dept Pediat & Genet, Chapel Hill, NC 27515 USA
[5] Univ N Carolina, Dept Maternal & Child Hlth, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA
关键词
population-based study; primary congenital glaucoma; risk factors; ALCOHOL-CONSUMPTION; GESTATIONAL-AGE; GENE-MUTATIONS; MEDICATION USE; CYP1B1; PREGNANCY; INFANTS; SMOKING; WEIGHT; BORN;
D O I
10.1002/ajmg.a.61296
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Primary congenital glaucoma (PCG) is a rare but serious birth defect. Genetic mutations have been implicated in the development of PCG, but little is known about nongenetic risk factors. This study investigates potential risk factors for PCG in the National Birth Defects Prevention Study (NBDPS), a large population-based case-control study of major birth defects in the United States. The analysis includes case infants with PCG (N = 107) and control infants without birth defects (N = 10,084) enrolled in NBDPS from birth years 2000-2011. Pregnancy/infant clinical characteristics, demographics, and parental health history were collected through maternal interview. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were computed to examine associations with all PCG cases and isolated PCG cases without other major malformations. Associations with all the cases included term low birth weight (<2,500 g; aOR = 2.80, CI 1.59-4.94), non-Hispanic black maternal race/ethnicity (aOR = 2.42, CI 1.42-4.13), maternal history of seizure (aOR = 2.73, CI 1.25-5.97), maternal antihypertensive use (aOR = 3.60, CI 1.52-8.53), and maternal sexually transmitted infection (aOR = 2.75, CI 1.17-6.44). These factors were also associated with isolated PCG, as was maternal use of nonsteroidal anti-inflammatory drugs (aOR = 2.70, CI 1.15-6.34). This study is among the first to examine a wide array of potential risk factors for PCG in a population-based sample.
引用
收藏
页码:1846 / 1856
页数:11
相关论文
共 50 条
[41]   Maternal antihypertensive medication use and selected birth defects in the National Birth Defects Prevention Study [J].
Fisher, Sarah C. ;
Van Zutphen, Alissa R. ;
Werler, Martha M. ;
Romitti, Paul A. ;
Cunniff, Christopher ;
Browne, Marilyn L. .
BIRTH DEFECTS RESEARCH, 2018, 110 (19) :1433-1442
[42]   Metformin in the first trimester and risks for specific birth defects in the National Birth Defects Prevention Study [J].
Dukhovny, Stephanie ;
Van Bennekom, Carla M. ;
Gagnon, David R. ;
Diaz, Sonia Hernandez ;
Parker, Samantha E. ;
Anderka, Marlene ;
Werler, Martha M. ;
Mitchell, Allen A. .
BIRTH DEFECTS RESEARCH, 2018, 110 (07) :579-586
[43]   Maternal Hypertension, Medication Use, and Hypospadias in the National Birth Defects Prevention Study [J].
Van Zutphen, Alissa R. ;
Werler, Martha M. ;
Browne, Marilyn M. ;
Romitti, Paul A. ;
Bell, Erin M. ;
McNutt, Louise-Anne ;
Druschel, Charlotte M. ;
Mitchell, Allen A. .
OBSTETRICS AND GYNECOLOGY, 2014, 123 (02) :309-317
[44]   Fever and antibiotic use in maternal urinary tract infections during pregnancy and risk of congenital heart defects: Findings from the National Birth Defects Prevention Study [J].
Patel, Jenil ;
Politis, Maria D. ;
Howley, Meredith M. ;
Browne, Marilyn L. ;
Bolin, Elijah H. ;
Ailes, Elizabeth C. ;
Johnson, Candice Y. ;
Magann, Everett ;
Nembhard, Wendy N. .
BIRTH DEFECTS RESEARCH, 2024, 116 (01)
[45]   The National Birth Defects Prevention Study: How to communicate data [J].
Scialli, Anthony R. .
SEMINARS IN FETAL & NEONATAL MEDICINE, 2014, 19 (03) :170-176
[46]   Maternal Exposure to Criteria Air Pollutants and Congenital Heart Defects in Offspring: Results from the National Birth Defects Prevention Study [J].
Stingone, Jeanette A. ;
Luben, Thomas J. ;
Daniels, Julie L. ;
Fuentes, Montserrat ;
Richardson, David B. ;
Aylsworth, Arthur S. ;
Herring, Amy H. ;
Anderka, Marlene ;
Botto, Lorenzo ;
Correa, Adolfo ;
Gilboa, Suzanne M. ;
Langlois, Peter H. ;
Mosley, Bridget ;
Shaw, Gary M. ;
Siffel, Csaba ;
Olshan, Andrew F. .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2014, 122 (08) :863-872
[47]   Maternal Butalbital Use and Selected Defects in the National Birth Defects Prevention Study [J].
Browne, Marilyn L. ;
Van Zutphen, Alissa R. ;
Botto, Lorenzo D. ;
Louik, Carol ;
Richardson, Sandra ;
Druschel, Charlotte M. .
HEADACHE, 2014, 54 (01) :54-66
[48]   Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997-2011 [J].
Tinker, Sarah C. ;
Reefhuis, Jennita ;
Bitsko, Rebecca H. ;
Gilboa, Suzanne M. ;
Mitchell, Allen A. ;
Tran, Emmy L. ;
Werler, Martha M. ;
Broussard, Cheryl S. .
BIRTH DEFECTS RESEARCH, 2019, 111 (10) :613-620
[49]   Congenital Heart Defects and the Risk of Spontaneous Preterm Birth [J].
Matthiesen, Niels B. ;
Ostergaard, John R. ;
Hjortdal, Vibeke E. ;
Henriksen, Tine B. .
JOURNAL OF PEDIATRICS, 2021, 229 :168-+
[50]   Assessing associations between residential proximity to greenspace and birth defects in the National Birth Defects Prevention Study [J].
Weber, Kari A. ;
Yang, Wei ;
Carmichael, Suzan L. ;
Collins, R. Thomas ;
Luben, Thomas J. ;
Desrosiers, Tania A. ;
Insaf, Tabassum Z. ;
Le, Mimi T. ;
Evans, Shannon Pruitt ;
Romitti, Paul A. ;
Yazdy, Mahsa M. ;
Nembhard, Wendy N. ;
Shaw, Gary M. .
ENVIRONMENTAL RESEARCH, 2023, 216